Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Umbilical cord tissue mesenchymal stem cells for severe COVID-19
RBR-4jh63bPhase 2Not yet recruiting
- Sponsor
- StemCorp
- Start
- Jul 2021
- Modality
- Stem Cell Therapies → Cell Therapies
- Countries
- 1
01
Overview
Phase 2, open-label trial of umbilical cord tissue mesenchymal stem cells in coronavirus disease 2019 (COVID-19) (2 arms), sponsored by StemCorp. Planned start Jul 2021; status: not yet recruiting.
02
Drugs
umbilical cord tissue mesenchymal stem cells
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on RBR-4jh63b.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on RBR-4jh63b.